|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Atara Biotherapeutics, Inc. (ATRA) |
|
|
$0.39 0.00 (0.00%) as of 4:30 Tue 6/18
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
108,674,000 |
| Market
Cap: |
42.88(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2298 - $2.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 707 |
| Guru Rank Value : 1.9 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
816,825 |
816,825 |
| Total Buy Value |
$0 |
$0 |
$194,885 |
$194,885 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
4 |
4 |
| Total Shares Sold |
211,204 |
267,396 |
419,842 |
591,605 |
| Total Sell Value |
$130,313 |
$170,773 |
$340,560 |
$980,941 |
| Total People Sold |
5 |
5 |
6 |
9 |
| Total Sell Transactions |
5 |
10 |
23 |
41 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-09-24 |
4 |
AS |
$42.17 |
$110,977 |
I/I |
(2,600) |
402,411 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-09-23 |
4 |
AS |
$43.29 |
$112,554 |
I/I |
(2,600) |
405,011 |
|
- |
|
| Seidenberg Beth C |
Director |
– • – |
2015-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
48,628 |
197 |
|
- |
|
| Seidenberg Beth C |
Director |
– • – |
2015-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,693 |
3,693 |
|
- |
|
| Seidenberg Beth C |
Director |
– • – |
2015-09-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(343,518) |
4,716 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-09-11 |
4 |
AS |
$47.74 |
$4,774 |
D/D |
(100) |
407,611 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-09-11 |
4 |
AS |
$45.42 |
$115,947 |
I/I |
(2,500) |
407,711 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-09-10 |
4 |
AS |
$44.67 |
$119,324 |
I/I |
(2,600) |
410,211 |
|
- |
|
| Haqq Christopher |
Chief Medical Officer |
• – – |
2015-08-31 |
4 |
AS |
$41.61 |
$209,961 |
D/D |
(5,000) |
240,890 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-08-28 |
4 |
AS |
$39.20 |
$102,877 |
I/I |
(2,600) |
374,982 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-08-27 |
4 |
AS |
$38.15 |
$101,209 |
I/I |
(2,600) |
377,582 |
|
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2015-08-24 |
4 |
AS |
$38.44 |
$237,936 |
D/D |
(5,874) |
91,916 |
|
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2015-08-21 |
4 |
AS |
$41.65 |
$245,015 |
D/D |
(5,874) |
97,790 |
|
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2015-08-20 |
4 |
AS |
$43.24 |
$263,139 |
D/D |
(5,874) |
103,664 |
|
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2015-08-19 |
4 |
AS |
$47.98 |
$283,083 |
D/D |
(5,875) |
109,538 |
|
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2015-08-18 |
4 |
AS |
$49.38 |
$284,626 |
D/D |
(5,764) |
115,413 |
|
- |
|
| Mcgrath John |
Chief Financial Officer |
• – – |
2015-08-18 |
4 |
AS |
$49.38 |
$296,280 |
D/D |
(6,000) |
31,854 |
|
- |
|
| Soffer Gad |
Chief Operating Officer |
• – – |
2015-08-18 |
4 |
AS |
$49.26 |
$381,626 |
D/D |
(7,711) |
65,837 |
|
- |
|
| Fust Matthew K |
Director |
– • – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,603 |
9,081 |
|
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
58,521 |
121,177 |
|
- |
|
| Mcgrath John |
Chief Financial Officer |
• – – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,502 |
37,854 |
|
- |
|
| Clark Mitchall G. |
Chief R & QA Officer |
• – – |
2015-08-17 |
4 |
AS |
$46.19 |
$361,622 |
D/D |
(7,829) |
34,130 |
|
- |
|
| Clark Mitchall G. |
Chief R & QA Officer |
• – – |
2015-08-17 |
4 |
OE |
$0.00 |
$37,628 |
D/D |
11,375 |
41,959 |
|
- |
|
| Soffer Gad |
Chief Operating Officer |
• – – |
2015-08-17 |
4 |
AS |
$50.00 |
$438,900 |
D/D |
(8,778) |
73,548 |
|
- |
|
| Soffer Gad |
Chief Operating Officer |
• – – |
2015-08-17 |
4 |
OE |
$0.00 |
$30,558 |
D/D |
16,538 |
82,326 |
|
- |
|
736 Records found
|
|
Page 27 of 30 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
